Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bernhard, Helga
268  Ergebnisse:
Personensuche X
?
1

Response-guided first-line therapy and treatment of relapse..:

Dührsen, Ulrich ; Bockisch, Andreas ; Hertenstein, Bernd...
Blood Neoplasia.  1 (2024)  3 - p. 100018 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Comparison of IGLV2‐14 light chain sequences of patients wi..:

Berghaus, Natalie ; Schreiner, Sarah ; Poos, Alexandra M....
The FEBS Journal.  290 (2023)  17 - p. 4256-4267 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Survival after secondary liver resection in metastatic colo..:

Moehler, Markus ; Folprecht, Gunnar ; Heinemann, Volker...
International Journal of Cancer.  150 (2021)  8 - p. 1341-1349 , 2021
Link: https://doi.org/10.1002/..
 
?
4

Lenalidomide versus bortezomib maintenance after frontline ..:

Baertsch, Marc-Andrea ; Mai, Elias K. ; Hielscher, Thomas...
Blood Cancer Journal.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Prognostic Impact of Serum Free Light Chain Ratio Normaliza..:

Klein, Eva-Maria ; Tichy, Diana ; Salwender, Hans...
Cancers.  13 (2021)  19 - p. 4856 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Publisher Correction: Bortezomib-based induction, high-dose..:

Mai, Elias K. ; Miah, Kaya ; Bertsch, Uta...
Leukemia.  35 (2021)  12 - p. 3636-3636 , 2021
Link: https://doi.org/10.1038/..
 
?
7

Bortezomib-based induction, high-dose melphalan and lenalid..:

Mai, Elias K. ; Miah, Kaya ; Bertsch, Uta...
Leukemia.  35 (2020)  3 - p. 809-822 , 2020
Link: https://doi.org/10.1038/..
 
?
8

Adjuvant MUC vaccination with tecemotide after resection of..:

Schimanski, Carl Christoph ; Kasper, Stefan ; Hegewisch-Becker, Susanna...
OncoImmunology.  9 (2020)  1 - p. , 2020
Link: https://doi.org/10.1080/..
 
?
9

Response-adapted lenalidomide maintenance in newly diagnose..:

for the German-speaking Myeloma Multicenter Group (GMMG) ; Goldschmidt, Hartmut ; Mai, Elias K....
Leukemia.  34 (2020)  7 - p. 1853-1865 , 2020
Link: https://doi.org/10.1038/..
 
?
10

Six versus eight doses of rituximab in patients with aggres..:

Hüttmann, Andreas ; Rekowski, Jan ; Müller, Stefan P....
Annals of Hematology.  98 (2019)  4 - p. 897-907 , 2019
Link: https://doi.org/10.1007/..
 
?
11

A phase I/IIa study of the mRNA-based cancer immunotherapy ..:

Sebastian, Martin ; Schröder, Andreas ; Scheel, Birgit...
Cancer Immunology, Immunotherapy.  68 (2019)  5 - p. 799-812 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Normalization of serum free light chains during therapy in ..:

Haas, Eva-Maria ; Salwender, Hans J. ; Mai, Elias K....
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e208 , 2019
Link: https://doi.org/10.1016/..
 
?
13

ATIM-40. HIGH RATE OF OBJECTIVE ANTI-TUMOR RESPONSE IN 9 PA..:

Geletneky, Karsten ; Bartsch, Andreas ; Weiss, Christian...
Neuro-Oncology.  20 (2018)  suppl_6 - p. vi10-vi10 , 2018
Link: https://doi.org/10.1093/..
 
?
14

ATIM-29. FIRST CLINICAL OBSERVATION OF IMPROVED ANTI-TUMOR ..:

Geletneky, Karsten ; Weiss, Christian ; Bernhard, Helga...
Neuro-Oncology.  18 (2016)  suppl_6 - p. vi24-vi24 , 2016
Link: https://doi.org/10.1093/..
 
?
15

A high‐throughputRNAi screen for detection of immune‐checkp..:

Khandelwal, Nisit ; Breinig, Marco ; Speck, Tobias...
EMBO Molecular Medicine.  7 (2015)  4 - p. 450-463 , 2015
Link: https://doi.org/10.15252..
 
1-15